A recent study [24] analyzed whether HLA-C and KIR genotypes were associated with treatment outcome for chronic hepatitis B infection (CHB) showing that the combination of KIR2DL1 with its ligand HLA-C2 is predictive of clinical outcome of infection predicted. Here, KIR3DL1 is linked to infection.